Accomplished industry leader brings specialized experience to advance Freenome's screening blood tests for colorectal cancer, lung cancer and additional indications…
NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased…
Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. ANN ARBOR, Mich., April 7, 2025…
SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing…
NEW YORK, April 3, 2025 /PRNewswire/ -- The Mark Foundation for Cancer Research convened more than 150 scientists from 13 states…
KENNEWICK, Wash., April 3, 2025 /PRNewswire/ -- Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring and sleep solutions, launched its…
Consistent with prior studies, published results from Castle’s DECIDE study show DecisionDx-Melanoma can both accurately identify patients with less than…
BOSTON, April 2, 2025 /PRNewswire/ -- PerZeption Inc., a U.S. vision diagnostics startup dedicated to preventing vision loss with novel…
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 2, 2025 /PRNewswire/ -- Equity Insider News Commentary – Artificial…
IRVINE, Calif., April 2, 2025 /PRNewswire/ -- University Lab Partners (ULP) proudly announces the selection of nine cutting-edge MedTech companies…